Telik gives Telcyta ASSIST updates

TELK completed enrollment of 440 patients in the international Phase III ASSIST-1 trial of Telcyta ( TLK286)

Read the full 174 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE